Effects of different doses of esketamine on hemodynamic indexes, pain stress indexes, and VAS scores in patients with benign ovarian tumors undergoing laparoscopic resection induced by remifentanil

This study aimed to investigate the effects of different doses of esketamine on hemodynamic indicators, pain stress indicators and Visual Analog Scale (VAS) scores in patients undergoing laparoscopic resection for benign ovarian tumors induced by remifentanil. A total of 110 patients with benign ovarian tumors scheduled for laparoscopic resection between June and December 2023 were included in the study and divided into three groups: Group A (35 cases), Group B (37 cases), and Group C (38 cases), based on their anesthesia regimen. Anesthesia induction for all groups included propofol, remifentanil, and cisatracurium. Group A received an intravenous dose of 0.8 mg/kg esketamine, Group B received 0.6 mg/kg esketamine and Group C did not receive esketamine. The results revealed statistically significant differences in average arterial pressure and heart rate at various time points within each group (p < 0.05), and significant differences were observed in Substance P (SP) and Prostaglandin E2 (PEG2) at three different time points within each group (p < 0.05). VAS scores during and after surgery at 6 and 12 hours significantly differed among the three groups (p < 0.05). There was a significant difference in awakening time among the three groups (p < 0.05). However, there were no statistically significant differences in the incidence of adverse reactions among the three groups (p > 0.05). In conclusion, both 0.6 mg/kg and 0.8 mg/kg doses of esketamine effectively prevented remifentanil-induced hyperalgesia in patients undergoing laparoscopic resection for benign ovarian tumors, significantly reducing patient pain. Notably, the 0.6 mg/kg dose of esketamine demonstrated better hemodynamic stability, promoted patient recovery, and showed superior clinical utility compared to the 0.8 mg/kg dose.

Different doses; Esketamine; Remifentanil; Laparoscopic resection of benign ovarian tumors; Hemodynamics; VAS score

[1] Metogo JAM, Nana TN, Ngongheh BA, Nyuydzefon EB, Adjahoung CA, Tochie JN, et al. General versus regional anaesthesia for caesarean section indicated for acute foetal distress: a retrospective cohort study. BMC Anesthesiology. 2021; 21: 68.

[2] Vannucci A, Riordan IR, Prifti K, Sebastiani A, Helsten DL, Lander DP, et al. Prolonged time to extubation after general anesthesia is associated with early escalation of care. European Journal of Anaesthesiology. 2021; 38: 494–504.

[3] Zhang L, Zhao Y, Gao T, Zhang H, Li J, Wang G, et al. Artesunate reduces remifentanil-induced hyperalgesia and peroxiredoxin-3 hyperacetylation via modulating spinal metabotropic glutamate receptor 5 in rats. Neuroscience. 2022; 487: 88–98.

[4] Horii Y, Matsuda M, Takemura H, Ishikawa D, Sawa T, Amaya F. Spinal and peripheral mechanisms individually lead to the development of remifentanil-induced hyperalgesia. Neuroscience. 2020; 446: 28–42.

[5] Ren WX, Matsusaki T, Bright AO, Morimatsu H. Association between the remifentanil dose during anesthesia and postoperative pain. Acta Medica Okayama. 2022; 76: 187–193.

[6] McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. American Journal of Psychiatry. 2021; 178: 383–399.

[7] Bahji A, Vazquez GH, Zarate CA. Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis. Journal of Affective Disorders. 2021; 278: 542–555.

[8] Wikkelsø AJ, Secher EL, Edwards H. General or regional anesthesia for postpartum haemorrhage—a national population‐based cohort study. Acta Anaesthesiologica Scandinavica. 2022; 66: 103–113.

[9] Khan A, Patrick A, Patil V, Nnochiri A, Wijayatilake S. The obstetric patient in the Covid pandemic: anaesthesia and perioperative care. Current Opinion in Obstetrics & Gynecology. 2021; 33: 361–369.

[10] Goerig M. A German-German fate: Heinz Ruppert—a forgotten pioneer of peridural anaesthesia and the last ship’s doctor of the PAMIR. Anaesthesist. 2022; 71: 220–232. (In German)

[11] Fujii T, Nishiwaki K. Ketamine reduces the dose of remifentanil required during prolonged head and neck surgery: a propensity-matched analysis. Nagoya Journal of Medical Science. 2022; 84: 1–6.

[12] Shu R, Zhang L, Zhang H, Li Y, Wang C, Su L, et al. NMDA receptor modulates spinal iron accumulation via activating DMT1(−)IRE in remifentanil-induced hyperalgesia. The Journal of Pain. 2021; 22: 32–47.

[13] Cappoli N, Aceto P, Tabolacci E, Mezzogori D, Sollazzi L, Navarra P, et al. Effects of remifentanil on human C20 microglial pro-inflammatory activation. European Review for Medical and Pharmacological Sciences. 2021; 25: 5268–5274.

[14] Bozymski KM, Crouse EL, Titus-Lay EN, Ott CA, Nofziger JL, Kirkwood CK. Esketamine: a novel option for treatment-resistant depression. Annals of Pharmacotherapy. 2020; 54: 567–576.

[15] Nikayin S, Murphy E, Krystal JH, Wilkinson ST. Long-term safety of ketamine and esketamine in treatment of depression. Expert Opinion on Drug Safety. 2022; 21: 777–787.

[16] Wehrfritz A, Bauer M, Noel N, Ramirez-Gil JF, Ihmsen H, Prottengeier J, et al. Evaluation of antihyperalgesic and analgesic effects of 35% nitrous oxide when combined with remifentanil. European Journal of Anaesthesiology. 2021; 38: 1230–1241.

[17] Lo C, Schwindt S, Sharma R, Dubé R, Faraoni D, Steinberg BE, et al. Association between intraoperative remifentanil dosage and postoperative opioid consumption in adolescent idiopathic spine surgery: a retrospective cohort study. Anesthesia & Analgesia. 2021; 133: 984–990.

[18] Raimondo D, Borghese G, Mastronardi M, Mabrouk M, Salucci P, Lambertini A, et al. Laparoscopic surgery for benign adnexal conditions under spinal anaesthesia: towards a multidisciplinary minimally invasive approach. Journal of Gynecology Obstetrics and Human Reproduction. 2020; 49: 101813.